Scientific consortium provides real-time risk assessment of SARS-CoV-2 variants on immune protection: Program employs a coordinated approach and serves as a template for response against rapidly evolving pandemic pathogens

A new program has been set up to provide a real-time risk assessment of variants of SARS-CoV-2, the virus that causes COVID-19. The program assesses how the variants might affect transmission, virulence, and resistance to both disease-induced (convalescent) and vaccine-induced immunity.

Leave a Comment